Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant

Zhifang Zhou, Han Lin, Chen Li, Zhimeng Wu

PDF(492 KB)
中国化学快报 ›› 2018, Vol. 29 ›› Issue (01) : 19-26. DOI: 10.1016/j.cclet.2017.09.047
评论

Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2018, 29(01): 19-26 https://doi.org/10.1016/j.cclet.2017.09.047
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 29(01): 19-26 https://doi.org/10.1016/j.cclet.2017.09.047

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(492 KB)

Accesses

Citation

Detail
段落导航
相关文章
　 版权所有 © 《中国化学快报》编辑部
邮编：100050 　电话：86-10-63165638　
E-mail：cclbj@imm.ac.cn
本系统由北京玛格泰克科技发展有限公司设计开发

/

〈 〉